Chen, P., Fang, M., Wan, Q., Zhang, X., Song, T., & Wu, S. (2017). High-sensitivity modified Glasgow prognostic score (HS-mGPS) Is superior to the mGPS in esophageal cancer patients treated with chemoradiotherapy. Oncotarget.
Chicago Stili AlıntıChen, Peng, Min Fang, Qiuyan Wan, Xuebang Zhang, Tao Song, ve Shixiu Wu. "High-sensitivity Modified Glasgow Prognostic Score (HS-mGPS) Is Superior to the MGPS in Esophageal Cancer Patients Treated With Chemoradiotherapy." Oncotarget 2017.
MLA AlıntıChen, Peng, et al. "High-sensitivity Modified Glasgow Prognostic Score (HS-mGPS) Is Superior to the MGPS in Esophageal Cancer Patients Treated With Chemoradiotherapy." Oncotarget 2017.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..